261 related articles for article (PubMed ID: 15188000)
1. Evidence for colorectal cancer cell specificity of aspirin effects on NF kappa B signalling and apoptosis.
Din FV; Dunlop MG; Stark LA
Br J Cancer; 2004 Jul; 91(2):381-8. PubMed ID: 15188000
[TBL] [Abstract][Full Text] [Related]
2. Aspirin-induced nuclear translocation of NFkappaB and apoptosis in colorectal cancer is independent of p53 status and DNA mismatch repair proficiency.
Din FV; Stark LA; Dunlop MG
Br J Cancer; 2005 Mar; 92(6):1137-43. PubMed ID: 15770215
[TBL] [Abstract][Full Text] [Related]
3. The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling.
Dihlmann S; Siermann A; von Knebel Doeberitz M
Oncogene; 2001 Feb; 20(5):645-53. PubMed ID: 11313997
[TBL] [Abstract][Full Text] [Related]
4. Suppression of RelA/p65 nuclear translocation independent of IkappaB-alpha degradation by cyclooxygenase-2 inhibitor in gastric cancer.
Wong BC; Jiang Xh; Fan XM; Lin MC; Jiang SH; Lam SK; Kung HF
Oncogene; 2003 Feb; 22(8):1189-97. PubMed ID: 12606945
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice.
Yao M; Kargman S; Lam EC; Kelly CR; Zheng Y; Luk P; Kwong E; Evans JF; Wolfe MM
Cancer Res; 2003 Feb; 63(3):586-92. PubMed ID: 12566300
[TBL] [Abstract][Full Text] [Related]
6. Sulindac targets nuclear beta-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines.
Boon EM; Keller JJ; Wormhoudt TA; Giardiello FM; Offerhaus GJ; van der Neut R; Pals ST
Br J Cancer; 2004 Jan; 90(1):224-9. PubMed ID: 14710233
[TBL] [Abstract][Full Text] [Related]
7. The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action.
Smith ML; Hawcroft G; Hull MA
Eur J Cancer; 2000 Mar; 36(5):664-74. PubMed ID: 10738133
[TBL] [Abstract][Full Text] [Related]
8. [Rationale and prospects for the use of cyclooxygenase-2 (COX-2) inhibitors in colorectal cancer].
Buecher B; Heymann MF; Blottière HM
Gastroenterol Clin Biol; 2001 Nov; 25(11):967-78. PubMed ID: 11845047
[No Abstract] [Full Text] [Related]
9. Aspirin and the prevention of colorectal cancer.
Berman KS
N Engl J Med; 2003 Jun; 348(24):2466-7; author reply 2466-7. PubMed ID: 12803217
[No Abstract] [Full Text] [Related]
10. Cancer research. Anti-inflammatories inhibit cancer growth--but how?
Marx J
Science; 2001 Jan; 291(5504):581-2. PubMed ID: 11233414
[No Abstract] [Full Text] [Related]
11. c-Src dependency of NSAID-induced effects on NF-κB-mediated apoptosis in colorectal cancer cells.
Brady RR; Loveridge CJ; Dunlop MG; Stark LA
Carcinogenesis; 2011 Jul; 32(7):1069-77. PubMed ID: 21551129
[TBL] [Abstract][Full Text] [Related]
12. Increased NF-kappaB DNA binding but not transcriptional activity during apoptosis induced by the COX-2-selective inhibitor NS-398 in colorectal carcinoma cells.
Smartt HJ; Elder DJ; Hicks DJ; Williams NA; Paraskeva C
Br J Cancer; 2003 Oct; 89(7):1358-65. PubMed ID: 14520472
[TBL] [Abstract][Full Text] [Related]
13. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway.
St-Germain ME; Gagnon V; Parent S; Asselin E
Mol Cancer; 2004 Mar; 3():7. PubMed ID: 15016316
[TBL] [Abstract][Full Text] [Related]
14. Expression of cyclooxygenase-2 parallels expression of interleukin-1beta, interleukin-6 and NF-kappaB in human colorectal cancer.
Maihöfner C; Charalambous MP; Bhambra U; Lightfoot T; Geisslinger G; Gooderham NJ;
Carcinogenesis; 2003 Apr; 24(4):665-71. PubMed ID: 12727794
[TBL] [Abstract][Full Text] [Related]
15. Growth inhibition of human colon cancer cells by nitric oxide (NO)-donating aspirin is associated with cyclooxygenase-2 induction and beta-catenin/T-cell factor signaling, nuclear factor-kappaB, and NO synthase 2 inhibition: implications for chemoprevention.
Williams JL; Nath N; Chen J; Hundley TR; Gao J; Kopelovich L; Kashfi K; Rigas B
Cancer Res; 2003 Nov; 63(22):7613-8. PubMed ID: 14633677
[TBL] [Abstract][Full Text] [Related]
16. The AKT/I kappa B kinase pathway promotes angiogenic/metastatic gene expression in colorectal cancer by activating nuclear factor-kappa B and beta-catenin.
Agarwal A; Das K; Lerner N; Sathe S; Cicek M; Casey G; Sizemore N
Oncogene; 2005 Feb; 24(6):1021-31. PubMed ID: 15592509
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2: a novel target for cancer chemotherapy?
Dempke W; Rie C; Grothey A; Schmoll HJ
J Cancer Res Clin Oncol; 2001 Jul; 127(7):411-7. PubMed ID: 11469677
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology and cellular/molecular mechanisms of action of aspirin and non-aspirin NSAIDs in colorectal cancer.
Schrör K
Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):473-84. PubMed ID: 22122764
[TBL] [Abstract][Full Text] [Related]
19. Aspirin inhibits Chlamydia pneumoniae-induced NF-kappa B activation, cyclo-oxygenase-2 expression and prostaglandin E2 synthesis and attenuates chlamydial growth.
Yoneda H; Miura K; Matsushima H; Sugi K; Murakami T; Ouchi K; Yamashita K; Itoh H; Nakazawa T; Suzuki M; Shirai M
J Med Microbiol; 2003 May; 52(Pt 5):409-415. PubMed ID: 12721317
[TBL] [Abstract][Full Text] [Related]
20. Ibuprofen inhibits activation of nuclear {beta}-catenin in human colon adenomas and induces the phosphorylation of GSK-3{beta}.
Greenspan EJ; Madigan JP; Boardman LA; Rosenberg DW
Cancer Prev Res (Phila); 2011 Jan; 4(1):161-71. PubMed ID: 21205744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
